| ENOVIS CORP. |
| USA |
| Gesundheit |
| US1940145022 / A3DHHV |
| C520 (Frankfurt) / ENOV (NYSE) |
| FRA:C520, ETR:C520, C520:GR, NYSE:ENOV |
| - |
| https://enovis.com/ |
|
Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. Enovis Corporation designs, manufactures, and distributes medical devices and services used across the patient ca..
>Volltext.. |
| 1058.25 Mio. EUR |
| 2242.43 Mio. EUR |
| 2043.8 Mio. EUR |
| 332.87 Mio. EUR |
| -978.95 Mio. EUR |
| -17.12 EUR |
| 1218.35 Mio. EUR |
| 11.18 Mio. EUR |
| 240.37 Mio. EUR |
| 0.02 |
| 8.19% |
| -37.11% |
| - |
| - |
| - |
| - |
| ENOVIS |
| 05.11.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|